Login / Signup

An integrated personalized assistive devices approach to reduce the risk of foot ulcer recurrence in diabetes (DIASSIST): study protocol for a multicenter randomized controlled trial.

Lisa E VossenJaap J Van NettenChantal D BakkerHeleen A BerendsenTessa E Busch-WestbroekEdgar Josephus Gerardus PetersLouise W E SabelisMarcel G W DijkgraafSicco A Bus
Published in: Trials (2023)
ClinicalTrials.gov NCT05236660. Registered on 11 February 2022.
Keyphrases
  • randomized controlled trial
  • type diabetes
  • study protocol
  • cardiovascular disease
  • glycemic control
  • free survival
  • cross sectional
  • double blind
  • metabolic syndrome